TWIN PEAKS WEALTH ADVISORS, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 2006218 BURLINGAME, CA

Position in GILD

as of Mar 31, 2026 · filed May 8, 2026 Compact

Position Value

$235,953

+$33,555 QoQ

Shares Held

1,693

+2.7% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.16%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

7 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

TWIN PEAKS WEALTH ADVISORS, LLC holds $3,898,189 across 6 Drug Manufacturers - General names.

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	1,331	$1,596,441
2	ABBV	AbbVie Inc.	3,187	$801,976
3	JNJ	Johnson & Johnson	2,930	$744,132
4	MRK	Merck & Co., Inc.	2,328	$299,148
5	AZN	Astrazeneca PLC	1,228	$232,853
6	NVS	Novartis AG	1,427	$223,639

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$235,953	1,693	+2.7%	Shares	Sole	2026-05-08
2025-12-31	$202,398	1,649	+10.7%	Shares	Sole	2026-02-10
2025-06-30	$165,085	1,489	-40.0%	Shares	Sole	2025-08-13
2024-12-31	$229,077	2,480	-14.0%	Shares	Sole	2025-02-04
2024-09-30	$241,878	2,885	-3.8%	Shares	Sole	2024-10-25
2024-03-31	$219,750	3,000	-6.2%	Shares	Sole	2024-04-23
2023-12-31	$258,988	3,197	—	Shares	Sole	2024-01-17
No filing history on record for this holder in this stock.